| Details
|
| UPD |
FurtherInformation Changed from
- Approved for the maintenance treatment of BRCA 1 or 2 mutated, relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer in people whose relapsed disease has responded to platinum-based&
|
10/10/2023 13:46:27
(DavidS )
|
| UPD |
Olaparib NICE TA886
|
10/10/2023 13:46:27
(DavidS )
|
| LDL |
Link Added : NICE TA886: Olaparib for adjuvant treatment of BRCA mutation-positive HER2-negative high-risk early breast cancer after chemotherapy : https://www.nice.org.uk/guidance/ta886
|
10/10/2023 13:45:55
(DavidS )
|
| UPD |
sitematrix Changed from 0 to
|
27/07/2022 15:35:17
(DavidS )
|
| UPD |
BlueTeq Changed from N to Y
|
27/07/2022 15:35:17
(DavidS )
|
| UPD |
Olaparib updated
|
27/07/2022 15:35:17
(DavidS )
|
| UPD |
sitematrix Changed from 0 to
|
27/07/2022 14:51:50
(DavidS )
|
| UPD |
FurtherInformation Changed from
- 50mg capsules
- Approved for the maintenance treatment of BRCA 1 or 2 mutated, relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer in people whose relapsed disease ha
|
27/07/2022 14:51:50
(DavidS )
|
| UPD |
Olaparib updated
|
27/07/2022 14:51:50
(DavidS )
|
| UPD |
sitematrix Changed from 0 to
|
26/04/2022 12:06:34
(DavidS )
|
| UPD |
FurtherInformation Changed from
- Approved for the maintenance treatment of BRCA 1 or 2 mutated, relapsed, platinum-sensitive ovarian, fallopian tube and pe
|
26/04/2022 12:06:34
(DavidS )
|
| UPD |
Olaparib updated
|
26/04/2022 12:06:34
(DavidS )
|
| UPD |
sitematrix Changed from 0 to
|
26/04/2022 11:35:20
(DavidS )
|
| UPD |
isCyto Changed from 0 to 1
|
26/04/2022 11:35:20
(DavidS )
|
| UPD |
FurtherInformation Changed from
- 50mg capsules
- Approved for the maintenance treatment of BRCA 1 or 2 mutated, relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancer in people whose relapsed disease ha
|
26/04/2022 11:35:20
(DavidS )
|
| UPD |
Olaparib updated
|
26/04/2022 11:35:20
(DavidS )
|
| UPD |
Olaparib updated formatting
|
19/05/2021 16:46:20
(DavidS )
|
| UPD |
Published from Draft Mode
|
21/05/2020 10:26:51
(LoweryM )
|
| LDL |
Link Added : NICE TA620: Olaparib for maintenance treatment of relapsed platinum-sensitive ovarian, fallopian tube or peritoneal cancer : https://www.nice.org.uk/guidance/ta620
|
20/05/2020 15:36:02
(DavidS )
|
| UPD |
Olaparib NICE TA620
|
20/05/2020 15:35:03
(DavidS )
|
| UPD |
Olaparib 50mg capsules updated
|
09/05/2018 11:32:11
(LoweryM )
|
| UPD |
Olaparib 50mg capsules updated
|
09/05/2018 11:31:54
(LoweryM )
|
| UPD |
Oliparib 50mg capsules b
|
01/02/2017 14:43:06
(DavidS )
|
| UPD |
Olaparib 50mg capsules b
|
24/01/2017 16:56:37
(WhitehallJ )
|
| UPD |
Olaparib 50mg capsules b
|
23/01/2017 14:10:24
(WhitehallJ )
|
| UPD |
Olaparib b
|
23/01/2017 14:09:39
(WhitehallJ )
|
